C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
AYRWF Equity

Ayr Wellness

OTCMKTS · AYRWF

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
46/100 composite
Fundamentals50
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

The model outputs a Neutral rating for Ayr Wellness, scoring 46/100 at conviction 2 of 5. The composite is a fixed blend of four pillars — fundamentals at 35 percent, regulatory at 25, market at 25, and editorial at 15 — and each contribution is inspectable. The strongest contribution comes from the regulatory pillar at 58, and pulls the composite into the middle of the band. Editorial lags at 30, softening what would otherwise be a stronger reading.

Pillar-level, the record reads as reported revenue growth of -9.1 percent year over year, an operating margin of -18.4 percent. Each of those data points tethers the Neutral conclusion to observable evidence. Every input flowing into the pillar table comes from primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, filtered through CIN newsroom density. The 336-ticker CIN universe is scored deterministically, so Ayr Wellness can be compared against the global cannabis coverage universe on identical inputs, refreshed on the ingest cycle.

The rating turns on regulatory pace. Filings landing at above the trailing-90-day cadence, combined with an unblemished enforcement record, would carry Ayr Wellness above the Neutral anchor; a lull would soften the read.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
199 BAY STREET, SUITE 5300, TORONTO, M5L 1B9
Phone
949-574-3860
SEC CIK
1847462
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$1.5M
Enterprise value
$598.2M
Price to book
0.00
Price to sales
0.00
EV / EBITDA
8.71
Revenue (TTM)
$452.9M
Gross profit (TTM)
$158.8M
EBITDA
$20.3M
Operating margin
-18.4%
Profit margin
-68.5%
Rev growth YoY
-9.1%
Return on equity
-68.0%
Return on assets
-2.6%
EPS (TTM)
$-2.65
Wall St. target price
$1.00
Shares outstanding
108.8M
Insider ownership
9.8%
Institutional ownership
0.7%
Beta
1.01
Full-time employees
2,500
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Ayr Wellness (AYRWF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Ayr Wellness (AYRWF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Bullish and bearish analyst opinions for Ayr Wellness (AYRWF)

Bullish view. Ayr Wellness operates verticals in Florida, Massachusetts, Pennsylvania, Ohio, and New Jersey and has been a wholesale share gainer in Massachusetts and Ohio; bulls model Florida adult-use as a step-change catalyst if the referendum passes, and Ohio as a leverageable adult-use market that scaled quickly.

Bearish view. Bearish views cite Ayr's balance-sheet leverage, near-term note maturities that require refinancing at higher rates, and the general MSO peer-group multiple compression that has affected leveraged names disproportionately.

Live ratings, price targets, and consensus figures for Ayr Wellness appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for AYRWF are maintained by Cannabis Investor News and refreshed throughout the trading day.